Research > ETFs > ETF / ETP Commentary > 

The Low-Cost Way of Investing in Cannabis

As world governments begin to soften their stance on cannabis, investors may have the opportunity to get in at the early stages of a blazing new industry that could touch upon many consumer and healthcare segments.In the upcoming webcast, The Low-Cost Way to Invest in Cannabis, Meb Faber, Co-Founder and CIO, Cambria Investment Management, will delve into the nascent cannabis sector and outline a targeted investment approach to help financial advisors hone in on the top companies in the rising cannabis industry.Specifically, the recently launched Cambria Cannabis ETF (TOKE), an actively managed ETF strategy backed by the Cambria management team, can target new opportunities and potentially some undervalued names in the cannabis space. Additionally, TOKE is the least expensive cannabis ETF available, with an annual fee of just 0.42%, or $42 on a $10,000 investment.The Cambria Cannabis ETF targets approximately 20 to 50 of the top companies with exposure to the broad cannabis industry based on Cambria’s determination as to their level of exposure to the industry. The ETF will typically invest in companies across a broad market capitalization spectrum of micro-, small-, and mid-capitalization stocks.The underlying selection methodology will pick out equity securities that provide broad exposure to the cannabis industry, including companies that engage in or support the legal production, cultivation, and/or sale of cannabis, including marijuana and hemp, such as certain agrobusiness, biotechnology, life sciences, pharmaceutical, retail, finance and real estate companies; perform lawful research as to the medical and pharmaceutical applications of marijuana and cannabis extracts, including cannabinoids; or produce and develop devices, goods, and equipment related to the cannabis industry, including hemp and its legal derivatives.The industry is also open to expand to other market segments. Cambria Investment Management expects that the industry will grow and crossover with other established industries such as tobacco, food, alcohol, medicine, tourism, and personal care. The definition of Cannabis Company will evolve as new business lines and products develop.This article originally appeared on ETFTrends.com

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.